| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | Chief Financial and Business Officer and Treasurer | Employee Stock Option (Right to Buy) | 213,000 | $2,858,460 | $13.42 | 23 Feb 2023 | Direct |
| Homology Medicines, Inc. | Chief Financial and Business Officer and Treasurer | Restricted Stock Units | 36,000 | $41,407 | $1.15 | 23 Feb 2023 | Direct |
| Homology Medicines, Inc. | Chief Financial and Business Officer and Treasurer | Common Stock | 14,219 | $8,048 | $0.5660 | 09 Jan 2023 | Direct |
| Lyra Therapeutics, Inc. | Director | Restricted Stock Units | 32,000 | 14 May 2025 | Direct | ||
| Lyra Therapeutics, Inc. | Director | Stock Option | 30,000 | 13 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | 14 May 2025 | 1 | $0 | 4 | Director | 16 May 2025, 16:30 |
| LYRA | Lyra Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:10 |
| LYRA | Lyra Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 21:52 |
| QTTB | Homology Medicines, Inc. | 23 Feb 2023 | 2 | $0 | 4 | Chief Financial and Business Officer and Treasurer | 27 Feb 2023, 15:05 |
| QTTB | Homology Medicines, Inc. | 09 Jan 2023 | 1 | -$5,188 | 4 | Chief Financial and Business Officer and Treasurer | 11 Jan 2023, 15:05 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2023 | 4 | $0 | 4 | Chief Financial and Business Officer and Treasurer Exhibit 24 - Power of Attorney | 04 Jan 2023, 15:34 |
| LYRA | Lyra Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:06 |
| QTTB | Homology Medicines, Inc. | 24 Feb 2022 | 2 | $0 | 4 | CFO & Treasurer | 28 Feb 2022, 15:06 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2022 | 3 | -$8,248 | 4 | CFO & Treasurer | 12 Jan 2022, 15:05 |
| LYRA | Lyra Therapeutics, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 18:23 |